NCT03018275: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03018275 |
|---|---|
| Title | Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic Dermatitis Phase I/II |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 20, 2017 |
| Completion date | Oct. 11, 2019 |
| Required reporting date | Oct. 10, 2020, midnight |
| Actual reporting date | June 9, 2020 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |